FDA Inspection 836704 — Discovery Laboratories, Inc.
The FDA completed an inspection of Discovery Laboratories, Inc. on Jun 5, 2013 in Warrington, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 5, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warrington, PA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)